Posting of Circular
30 Outubro 2008 - 7:00AM
UK Regulatory
RNS Number : 0179H
York Pharma plc
30 October 2008
York Pharma plc
("York Pharma" or "the Company")
Posting of Circular
London, UK, 30 October 2008 York Pharma plc (AIM: YRK), the pharmaceutical company focused on the field of dermatology, announces that
further to the Company's announcement on 28 October 2008, the Company is pleased to confirm that a circular will be sent to shareholders and
the holders of AIM warrants later today containing notices convening both an extraordinary general meeting of shareholders and a general
meeting of AIM warrant holders for 27 November 2008.
As set out in the Circular the expiry date of the warrants are being extended and Mr T I Sadler, CEO of York Pharma Plc is one of the
beneficiaries of this extension due to his holding 965,000 warrants.
--END--
For further information please contact:
York Pharma plc Tel: +44 (0)870 067 2563
Terry Sadler, Chief Executive Officer
FinnCap Tel: +44 (0)207 600 1658
Stephen Norcross
Collins Stewart Europe Limited Tel: +44 (0)207 8000 8350
Nick Ellis
Financial Dynamics Tel: +44 (0)207 831 3113
David Yates
Ben Brewerton
Emma Thompson
End
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCIIFFTITLIVIT
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre York Pharma da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de York Pharma Plc